Polymorphism of Interleukin-1 Gene Cluster in Polish Patients with Acute Coronary Syndrome

Overview

Journal J Clin Med

Specialty General Medicine

Date 2021 Apr 3

PMID 33801199

Citations 2

Authors

Tomasz Rechcinski

Bozena Szymanska

Karina Wierzbowska-Drabik

Magdalena Chmiela

Agnieszka Matusiak

Malgorzata Kurpesa

Janusz Wroblewski

Jaroslaw D Kasprzak

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Some experimental studies demonstrated adverse modulation of atherothrombosis by interleukin-1beta (IL-1b). To assess the relationship between the five most common variants of three polymorphisms of the IL1b gene cluster and the complexity of coronary atherosclerosis expressed in Gensini Score (GS), and the age of onset of the first acute coronary syndrome (ACS), we assessed the patients (pts) hospitalized due to ACS in this aspect.

Materials And Methods: 250 individuals were included. The single nucleotide polymorphisms of IL1b gene: transition T/C at -31 position, C/T at -511, and those of IL1 receptor antagonist gene (IL1RN)-variable number of tandem repeats allele 1, 2, 3, or 4-were determined by PCR. GS was calculated from the coronary angiogram performed at the index ACS. The impact of the presence of T or C and allele 1 to 4 at the investigated loci on the mean GS, GS greater than 40, mean age of onset of ACS, and the fraction of pts over 60 years of age at ACS were compared between the five most common genotype variants.

Results: The five most common variants were present in 203 pts (81.2%). Patients with pair 22 in ILRN had the lowest rate and those with pair 12 had the highest rate of ACS before 60 years of age (29.4 vs. 67.8%; = 0.004). GS > 40 entailed an eight-fold increase of risk, as observed when pts with one T allele at locus -31 were compared with carriers of 2 or no T allele at this locus: OR 8.73 [CI95 4.26-70.99] = 0.04.

Conclusion: Interleukin-1 beta is subject to frequent genetic variability and our results show a potential relationship of this polymorphism with the extent of coronary atherosclerosis and age at the first ACS.

Citing Articles

Investigating the relationship between the VNTR variant of the interleukin-1 receptor antagonist gene and coronary in-stent restenosis.

Klashami Z, Mostafavi A, Roudbordeh M, Abbasi A, Ebrahimi P, Asadi M Mol Biol Rep. 2023; 50(10):8575-8587.

PMID: 37644369 DOI: 10.1007/s11033-023-08759-w.

Interleukin-1 in Coronary Artery Disease.

Oikonomou E, Tsaplaris P, Anastasiou A, Xenou M, Lampsas S, Siasos G Curr Top Med Chem. 2022; 22(28):2368-2389.

PMID: 36263481 DOI: 10.2174/1568026623666221017144734.

References

Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R . Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol. 2004; 25(1):222-7. DOI: 10.1161/01.ATV.0000150039.60906.02. View

Jagielska J, Kapopara P, Salguero G, Scherr M, Schutt H, Grote K . Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells. Arterioscler Thromb Vasc Biol. 2012; 32(5):1280-8. DOI: 10.1161/ATVBAHA.111.243477. View

Brown G, McIntyre T . Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles. J Immunol. 2011; 186(9):5489-96. PMC: 3100655. DOI: 10.4049/jimmunol.1001623. View

Rad R, Prinz C, Neu B, Neuhofer M, Zeitner M, Voland P . Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis. 2003; 188(2):272-81. DOI: 10.1086/376458. View

Siwik D, Chang D, Colucci W . Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res. 2000; 86(12):1259-65. DOI: 10.1161/01.res.86.12.1259. View

Rechcinski T, Grebowska A, Kurpesa M, Peruga Z, Dziuba M, Krzeminska-Pakula M . CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases. Kardiol Pol. 2007; 65(3):237-44. View

Eklund C, Jahan F, Pessi T, Lehtimaki T, Hurme M . Interleukin 1B gene polymorphism is associated with baseline C-reactive protein levels in healthy individuals. Eur Cytokine Netw. 2003; 14(3):168-71. View

Goracy J, Goracy I, Safranow K, Taryma O, Adler G, Ciechanowicz A . Lack of association of interleukin-1 gene cluster polymorphisms with angiographically documented coronary artery disease: demonstration of association with hypertension in the Polish population. Arch Med Res. 2011; 42(5):426-32. DOI: 10.1016/j.arcmed.2011.08.002. View

Yang L, Guo X, Du C, Yang J, Jiang D, Li B . Interleukin-1 beta increases activity of human endothelial progenitor cells: involvement of PI3K-Akt signaling pathway. Inflammation. 2012; 35(4):1242-50. DOI: 10.1007/s10753-012-9434-9. View

10.

Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J . Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440(7081):237-41. DOI: 10.1038/nature04516. View

11.

Lindemann S, Tolley N, Dixon D, McIntyre T, Prescott S, Zimmerman G . Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol. 2001; 154(3):485-90. PMC: 2196422. DOI: 10.1083/jcb.200105058. View

12.

Tardif J, Kouz S, Waters D, Bertrand O, Diaz R, Maggioni A . Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019; 381(26):2497-2505. DOI: 10.1056/NEJMoa1912388. View

13.

Polonski L, Gasior M, Gierlotka M, Kalarus Z, Cieslinski A, Dubiel J . Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol Pol. 2007; 65(8):861-72. View

14.

Latella M, de Gaetano M, Di Castelnuovo A, Napoleone E, Lorenzet R, Gattone M . Interleukin 1 gene cluster, myocardial infarction at young age and inflammatory response of human mononuclear cells. Immunol Invest. 2009; 38(3-4):203-19. DOI: 10.1080/08820130902766142. View

15.

Dewberry R, HOLDEN H, Crossman D, Francis S . Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol. 2000; 20(11):2394-400. DOI: 10.1161/01.atv.20.11.2394. View

16.

Thygesen K, Alpert J, White H, Jaffe A, Apple F, Galvani M . Universal definition of myocardial infarction. Circulation. 2007; 116(22):2634-53. DOI: 10.1161/CIRCULATIONAHA.107.187397. View

17.

Arend W . The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002; 13(4-5):323-40. DOI: 10.1016/s1359-6101(02)00020-5. View

18.

Rogus J, Beck J, Offenbacher S, Huttner K, Iacoviello L, Latella M . IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein. Hum Genet. 2008; 123(4):387-98. DOI: 10.1007/s00439-008-0488-6. View

19.

Bassand J, Hamm C . New European guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction--what are the new and key messages. Pol Arch Med Wewn. 2007; 117(9):391-3. View

20.

Kam L, Chong Y, Fiocchi C, Pizarro T, Cominelli F . Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol. 1995; 154(5):2434-40. View